Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
30
NCT00418275
Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.
Phase: Phase 1/2
Role: Lead Sponsor
Start: Apr 30, 2001
Completion: Jun 30, 2004